Ions Invest Limited - Accounts to registrar - small 17.1.1
Ions Invest Limited - Accounts to registrar - small 17.1.1
REGISTERED NUMBER: |
Unaudited Financial Statements for the Year Ended 31 December 2016 |
for |
Ions Invest Limited |
Ions Invest Limited (Registered number: 04280886) |
Contents of the Financial Statements |
for the Year Ended 31 December 2016 |
Page |
Company Information | 1 |
Balance Sheet | 2 |
Notes to the Financial Statements | 3 |
Ions Invest Limited |
Company Information |
for the Year Ended 31 December 2016 |
DIRECTOR: |
SECRETARY: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
Ions Invest Limited (Registered number: 04280886) |
Balance Sheet |
31 December 2016 |
31.12.16 | 31.12.15 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Investments | 3 |
CURRENT ASSETS |
Cash at bank |
CREDITORS |
Amounts falling due within one year | 4 |
NET CURRENT LIABILITIES | ( |
) | ( |
) |
TOTAL ASSETS LESS CURRENT LIABILITIES | ( |
) | ( |
) |
CAPITAL AND RESERVES |
Called up share capital |
Share premium |
Retained earnings | ( |
) | ( |
) |
SHAREHOLDERS' FUNDS | ( |
) | ( |
) |
The director acknowledges his responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
The financial statements were approved by the director on |
Ions Invest Limited (Registered number: 04280886) |
Notes to the Financial Statements |
for the Year Ended 31 December 2016 |
1. | STATUTORY INFORMATION |
Ions Invest Limited is a |
registered number and registered office address can be found on the Company Information page. |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
Foreign currencies |
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the |
balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange |
ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating |
result. |
3. | FIXED ASSET INVESTMENTS |
Other |
investments |
£ |
COST |
At 1 January 2016 |
Additions |
At 31 December 2016 |
PROVISIONS |
At 1 January 2016 |
and 31 December 2016 | 1,220,665 |
NET BOOK VALUE |
At 31 December 2016 |
At 31 December 2015 |
The investment relates to a holding in Medesis Pharma. In the year the Company purchased 3,000 shares. As |
at the balance sheet date the Company held 561,261 shares which represents 22.4% of the issued share |
capital. |
4. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31.12.16 | 31.12.15 |
£ | £ |
Other creditors |
Loan - shareholders | 2,379,199 | 2,379,199 |